Home › Prescription medicine › InvaGen Pharmaceuticals, Inc. — Vigabatrin for…
InvaGen Pharmaceuticals, Inc. — Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Defective Container: powder may leak out of the pouch
The Recall Registry rates this highest risk — FDA Class I: reasonable probability of serious harm or death.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: InvaGen Pharmaceuticals, Inc.
The product
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
Details
- Units affected
- 1240 boxes
- Recall date
- November 17, 2023
- Brand
- InvaGen Pharmaceuticals, Inc.
Nationwide within the United States
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “InvaGen Pharmaceuticals, Inc. — Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla US”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine